Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions
Acquiring Company
Johnson & Johnson Innovative Medicine Ireland
Acquired Company
ShockWave Medical
Santa Clara CountyBiotechnologyHealth CareMedicalMedical DeviceTherapeuticsBiotechnologyHealthcareHealth CareMedicalMedical DeviceTherapeuticsDescription
Johnson & Johnson (J&J) reaffirms its commitment to advancing cardiac health solutions with the strategic acquisition of Shockwave Medical for $12.5 billion. This acquisition underscores J&J's dedication to expanding its portfolio in treating heart diseases and enhances its position in the competitive medical device market.
Quick answer
Johnson & Johnson Innovative Medicine Ireland is acquiring ShockWave Medical for $12.5 billion, announced April 5, 2024.
- How much did Johnson & Johnson Innovative Medicine Ireland pay for ShockWave Medical?
- The reported deal value is $12.5 billion.
- What does Johnson & Johnson Innovative Medicine Ireland do?
- Johnson & Johnson Innovative Medicine Ireland innovates with purpose to lead where medicine is going.
- Where are Johnson & Johnson Innovative Medicine Ireland and ShockWave Medical based?
- ShockWave Medical is based in Santa Clara County, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Harmony Biosciences acquires Epygenix Therapeutics, Inc. to expand rare epilepsy franchise (April 30, 2024)
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- XOMA Corporation successfully acquires Kinnate Biopharma Inc. (April 3, 2024)
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (March 25, 2024)
Who to call at Johnson & Johnson Innovative Medicine Ireland, and when
When Johnson & Johnson Innovative Medicine Ireland changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Johnson & Johnson Innovative Medicine Ireland raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Johnson & Johnson Innovative Medicine Ireland, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Johnson & Johnson Innovative Medicine Ireland. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Johnson & Johnson Innovative Medicine Ireland makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired ShockWave Medical?
ShockWave Medical was acquired by Johnson & Johnson Innovative Medicine Ireland. The deal was reported on April 5, 2024. Johnson & Johnson Innovative Medicine Ireland innovates with purpose to lead where medicine is going. Its ambition is to tackle the toughest health challenges, where patient need is highest. Johnson & Johnson Innovative Medicine Ireland is privately held and operates in Biotechnology.
When did Johnson & Johnson Innovative Medicine Ireland acquire ShockWave Medical?
Johnson & Johnson Innovative Medicine Ireland's acquisition of ShockWave Medical was reported on April 5, 2024. Johnson & Johnson (J&J) reaffirms its commitment to advancing cardiac health solutions with the strategic acquisition of Shockwave Medical for $12.5 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ShockWave Medical do?
ShockWave Medical focuses on developing and commercializing intravascular lithotripsy technology used to treat calcified cardiovascular disease. Their innovative systems deliver sonic pressure waves to modify hard calcium deposits in arterial walls. It is privately held, operating in Biotechnology, and is based in Santa Clara County.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.